Clinical analysis of low-dos erituximab in the treatment of refractory idiopathic membranous nephropathy

Objective To explore the efficacy and safety of low-dose rituximab(RTX)for refractory idiopathic membranous nephropathy(IMN).Methods From January 2017 to December 2018,32 cases of refractory IMN with positive anti-PLA2 R antibody were collected.They received low-dose RTX treatment and were followed...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuan Zhong-fei, Liu Xian-yan, He Jian
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2021-01-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails?columnId=57905525&Fpath=home&index=0
Tags: Add Tag
No Tags, Be the first to tag this record!